USPTO Examiner COOK CHRISTOPHER L - Art Unit 3797

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
18625781METHODS AND DEVICES FOR SONOGRAPHIC IMAGINGApril 2024April 2025Allow1220NoNo
18416759TELEOPERATED SURGICAL SYSTEM WITH SURGEON SKILL LEVEL BASED INSTRUMENT CONTROLJanuary 2024May 2025Allow1620NoNo
18516387Systems and Methods for Targeted NeuromodulationNovember 2023December 2024Allow1310YesNo
18479669System and Methods Using Ultrasound for TreatmentOctober 2023January 2025Abandon1510NoNo
18463624SYSTEMS AND METHODS FOR FILTERING LOCALIZATION DATASeptember 2023March 2025Allow1810YesNo
18230770HANDLE SYSTEM FOR TRANSPORT, DOCK RETENTION AND DESKTOP POSITIONING OF A PORTABLE MEDICAL DEVICEAugust 2023March 2025Allow1920YesNo
18344758Systems and Methods Using Ultrasound for TreatmentJune 2023May 2025Abandon2220NoNo
18215259ELASTOGRAPHY FOR LIGAMENT CHARACTERIZATIONJune 2023July 2024Allow1310NoNo
18203304PHASED ARRAY INTRAVASCULAR DEVICES, SYSTEMS, AND METHODS UTILIZING PHOTOACOUSTIC AND ULTRASOUND TECHNIQUES`May 2023January 2025Abandon2020NoNo
18202199System For Determining Peripheral Artery Disease and Method of UseMay 2023November 2024Allow1720NoNo
18308281METAL DETECTOR FOR DETECTING INSERTION OF A SURGICAL DEVICE INTO A HOLLOW TUBEApril 2023March 2024Allow1110YesNo
18133721CONTRAST AGENT GENERATION AND INJECTION SYSTEM FOR SONOGRAPHIC IMAGINGApril 2023August 2024Allow1710NoNo
18131174METHODS AND DEVICES FOR SONOGRAPHIC IMAGINGApril 2023January 2024Allow1010NoNo
18189635METAL DETECTOR FOR DETECTING INSERTION OF A SURGICAL DEVICE INTO A HOLLOW TUBEMarch 2023October 2023Allow710NoNo
18151013NONINVASIVE FRAGMENTATION OF URINARY TRACT STONES WITH FOCUSED ULTRASOUNDJanuary 2023August 2024Allow2030YesNo
18074818DEVICES AND METHODS FOR MULTI-FOCUS ULTRASOUND THERAPYDecember 2022October 2023Allow1110YesNo
17776953SYSTEM FOR GIVING FEEDBACK BASED ON MOTION BEFORE OR DURING MEDICAL IMAGING AND CORRESPONDING METHODMay 2022April 2025Abandon3510NoNo
17589408System and Methods Using Ultrasound for TreatmentJanuary 2022January 2024Abandon2340YesYes
17602451COMBINED OPTICAL IMAGE GENERATOR AND OPTICAL IMAGING SYSTEMOctober 2021November 2024Allow3710NoNo
17484505ULTRASOUND APPARATUS AND METHOD OF DISPLAYING ULTRASOUND IMAGESSeptember 2021December 2023Allow2730YesNo
17437443NEEDLE GUIDE FOR AN ANGLED ENDOCAVITY TRANSDUCERSeptember 2021January 2025Allow4121YesNo
17435394Disposable Sterile Device and Method for Using Disposable Sterile DeviceSeptember 2021December 2024Abandon4001NoNo
17419332APPARATUS AND METHOD FOR TRACKING HEAD MOTION IN MAGNETIC RESONANCE IMAGING (MRI)June 2021May 2025Abandon4740YesNo
17349804VESSEL LOCATION ASSISTANCE DEVICEJune 2021September 2024Allow3940YesNo
172373972D-IMAGE GUIDED ROBOTIC DISTAL LOCKING SYSTEMApril 2021March 2025Allow4620YesYes
17286663COIL POSITIONING APPARATUSES, SYSTEMS, AND METHODS THEREOFApril 2021February 2025Allow4630YesNo
17190375SYSTEMS AND METHODS FOR SUBJECT POSITIONING AND IMAGE-GUIDED SURGERYMarch 2021May 2025Abandon5140NoNo
17260217SYSTEMS AND METHODS FOR DRY EYE ANALYSIS USING TERAHERTZ RADIATIONJanuary 2021April 2025Allow5130YesNo
16949950IMAGE GUIDED RADIATION THERAPY SYSTEM AND SHIELDED RADIO FREQUENCY DETECTOR COIL FOR USE THEREINNovember 2020March 2024Abandon4020NoNo
17063565Quantitative Imaging System and Uses ThereofOctober 2020March 2025Allow5420NoNo
17044488WEARABLE SYSTEM AND METHOD FOR DETERMINING BLOOD PRESSUREOctober 2020May 2024Abandon4401NoNo
17021642STERILE COVERS FOR ULTRASOUND PROBESeptember 2020February 2024Allow4120NoNo
16990804METHOD AND APPARATUS FOR IMPLANTATION OF A PACING ELECTRODEAugust 2020February 2024Allow4220YesNo
16967539Monitoring of Physiological ParametersAugust 2020January 2024Abandon4110NoNo
16940100ROBOTIC ARMS AND METHODS FOR TISSUE RESECTION AND IMAGINGJuly 2020May 2024Allow4660YesYes
16834656ROBOTIC SURGICAL APPARATUS WITH POSITIONING GUIDEMarch 2020February 2024Allow4730YesNo
16826114SYSTEMS AND METHODS FOR LOCALIZATION BASED ON MACHINE LEARNINGMarch 2020August 2024Allow5331YesNo
16647371PHOTOPLETHYSMOGRAPH DEVICE AND ELECTRONIC APPARATUSMarch 2020February 2024Abandon4720YesNo
16793886Robotic Surgical System and Method for Providing a Stadium View with Arm Set-Up GuidanceFebruary 2020November 2024Allow5750YesNo
16638660SYSTEMS AND METHODS FOR MONITORING PATIENT MOTION DURING A MEDICAL PROCEDUREFebruary 2020February 2024Allow4830YesNo
16724307MEDICAL IMAGE PROCESSING APPARATUS AND MEDICAL OBSERVATION SYSTEMDecember 2019October 2023Allow4640YesNo
16675690SURGICAL IMAGE-GUIDED NAVIGATION DEVICES AND RELATED SYSTEMSNovember 2019September 2023Allow4640YesNo
16563769METHODS AND SYSTEMS FOR MRI PATIENT PRESCREENINGSeptember 2019May 2025Allow6060YesNo
16468870SYSTEMS FOR AN MRI BREAST RF COIL ARRAYJune 2019December 2024Abandon6060YesNo
16349196TELEOPERATED SURGICAL SYSTEM WITH PATIENT HEALTH RECORDS BASED INSTRUMENT CONTROLMay 2019July 2024Allow6050YesNo
16349202TELEOPERATED SURGICAL SYSTEM WITH SURGEON SKILL LEVEL BASED INSTRUMENT CONTROLMay 2019November 2023Allow5430NoNo
16401965TRAINING SYSTEM FOR ROBOT-ASSISTED LAPAROSCOPIC SURGERYMay 2019September 2024Abandon6040NoNo
16314985ULTRASOUND AUTOFOCUSING USING REFLECTIONSJanuary 2019March 2024Allow6060YesNo
16216938NON-INVASIVE DIFFUSE ACOUSTIC CONFOCAL THREE-DIMENSIONAL IMAGINGDecember 2018February 2025Allow6041YesNo
16189085METHOD, SYSTEM, AND COMPUTER-ACCESSIBLE MEDIUM FOR ASSESSMENT OF GLYCOSAMINOGLYCAN CONCENTRATION IN VIVO BY CHEMICAL EXCHANGE SATURATION TRANSFERNovember 2018November 2024Abandon6030NoYes
16171241Diagnostic Method, Method for Validation of Diagnostic Method, and Treatment MethodOctober 2018August 2024Abandon6041YesNo
16094878DIAGNOSTIC SUPPORTOctober 2018August 2023Allow5830NoNo
16113501INFORMATION PROCESSING APPARATUSAugust 2018July 2024Abandon6050YesNo
16045209MEDICAL IMAGING APPARATUSJuly 2018November 2023Allow6050NoNo
15960249TISSUE IMAGING SYSTEM AND METHOD FOR TISSUE IMAGINGApril 2018April 2025Allow6051YesYes
15650633DIFFUSE ACOUSTIC CONFOCAL IMAGERJuly 2017November 2021Abandon5241YesYes
15025607DEVICE TRACKING USING LONGITUDINAL ENCODINGMarch 2016January 2025Abandon6060YesYes
13817329APPARATUS AND METHOD FOR GENERATING MECHANICAL WAVES INTO LIVING BODIES, SYSTEM AND METHOD FOR MAPPING AN ORGAN OR TISSUE AND SYSTEM AND METHOD FOR CHARACTERISING THE MECHANICAL PROPERTIES OF SAID ORGAN OR TISSUEMay 2013July 2024Abandon60100YesNo
12458812Medical imaging apparatusJuly 2009May 2013Allow4520YesNo
12491559METHOD FOR VISUALLY MONITORING AN IRREVERSIBLE ELECTROPORATION TREATMENT, AND MAGNETIC RESONANCE IMAGING APPARATUS WITH INTEGRATED ELECTROPORATION TREATMENT DEVICEJune 2009October 2012Allow4020YesYes
11592976METHOD OF MR IMAGINGNovember 2006August 2012Allow6030NoNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner COOK, CHRISTOPHER L.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
1
Examiner Affirmed
1
(100.0%)
Examiner Reversed
0
(0.0%)
Reversal Percentile
19.9%
Lower than average

What This Means

With a 0.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is in the bottom 25% across the USPTO, indicating that appeals face significant challenges here.

Strategic Value of Filing an Appeal

Total Appeal Filings
10
Allowed After Appeal Filing
1
(10.0%)
Not Allowed After Appeal Filing
9
(90.0%)
Filing Benefit Percentile
11.3%
Lower than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 10.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.

Strategic Recommendations

Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.

Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.

Examiner COOK, CHRISTOPHER L - Prosecution Strategy Guide

Executive Summary

Examiner COOK, CHRISTOPHER L works in Art Unit 3797 and has examined 59 patent applications in our dataset. With an allowance rate of 66.1%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 46 months.

Allowance Patterns

Examiner COOK, CHRISTOPHER L's allowance rate of 66.1% places them in the 19% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by COOK, CHRISTOPHER L receive 2.98 office actions before reaching final disposition. This places the examiner in the 95% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by COOK, CHRISTOPHER L is 46 months. This places the examiner in the 2% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.

Interview Effectiveness

Conducting an examiner interview provides a +22.8% benefit to allowance rate for applications examined by COOK, CHRISTOPHER L. This interview benefit is in the 72% percentile among all examiners. Recommendation: Interviews provide an above-average benefit with this examiner and are worth considering.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 23.1% of applications are subsequently allowed. This success rate is in the 22% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 12.9% of cases where such amendments are filed. This entry rate is in the 7% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 0.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 21% percentile among all examiners. Note: Pre-appeal conferences show limited success with this examiner compared to others. While still worth considering, be prepared to proceed with a full appeal brief if the PAC does not result in favorable action.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 83.3% of appeals filed. This is in the 75% percentile among all examiners. Of these withdrawals, 80.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows above-average willingness to reconsider rejections during appeals. The mandatory appeal conference (MPEP § 1207.01) provides an opportunity for reconsideration.

Petition Practice

When applicants file petitions regarding this examiner's actions, 40.0% are granted (fully or in part). This grant rate is in the 40% percentile among all examiners. Strategic Note: Petitions show below-average success regarding this examiner's actions. Ensure you have a strong procedural basis before filing.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 45% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 44% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prepare for rigorous examination: With a below-average allowance rate, ensure your application has strong written description and enablement support. Consider filing a continuation if you need to add new matter.
  • Expect multiple rounds of prosecution: This examiner issues more office actions than average. Address potential issues proactively in your initial response and consider requesting an interview early in prosecution.
  • Plan for RCE after final rejection: This examiner rarely enters after-final amendments. Budget for an RCE in your prosecution strategy if you receive a final rejection.
  • Plan for extended prosecution: Applications take longer than average with this examiner. Factor this into your continuation strategy and client communications.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.